153 related articles for article (PubMed ID: 28073124)
1. The Effects of Blood Glucose Regulation in Omentin-1 Levels among Diabetic Patients.
Arman Y; Kirna K; Ugurlukisi B; Kutlu O; Dikker O; Cil EO; Akarsu M; Ozcan M; Yuruyen G; Demir P; Altun O; Ozsenel EB; Erdem MG; Sandikci R; Tukek T
Exp Clin Endocrinol Diabetes; 2017 Apr; 125(4):262-266. PubMed ID: 28073124
[No Abstract] [Full Text] [Related]
2. Role of omentin 1 and IL-6 in type 2 diabetes mellitus patients with diabetic nephropathy.
Senthilkumar GP; Anithalekshmi MS; Yasir M; Parameswaran S; Packirisamy RM; Bobby Z
Diabetes Metab Syndr; 2018; 12(1):23-26. PubMed ID: 28864059
[TBL] [Abstract][Full Text] [Related]
3. Comparative effects of metformin and pioglitazone on omentin and leptin concentrations in patients with newly diagnosed diabetes: a randomized clinical trial.
Esteghamati A; Noshad S; Rabizadeh S; Ghavami M; Zandieh A; Nakhjavani M
Regul Pept; 2013 Mar; 182():1-6. PubMed ID: 23328000
[TBL] [Abstract][Full Text] [Related]
4. Changes of serum omentin-1 levels in normal subjects and in patients with impaired glucose regulation and with newly diagnosed and untreated type 2 diabetes.
Pan HY; Guo L; Li Q
Diabetes Res Clin Pract; 2010 Apr; 88(1):29-33. PubMed ID: 20129687
[TBL] [Abstract][Full Text] [Related]
5. Association between omentin levels and insulin resistance in pregnancy.
Aktas G; Alcelik A; Ozlu T; Tosun M; Tekce BK; Savli H; Tekce H; Dikbas O
Exp Clin Endocrinol Diabetes; 2014 Mar; 122(3):163-6. PubMed ID: 24643693
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin may mediate the association between omentin, circulating lipids and insulin sensitivity: results from the KORA F4 study.
Herder C; Ouwens DM; Carstensen M; Kowall B; Huth C; Meisinger C; Rathmann W; Roden M; Thorand B
Eur J Endocrinol; 2015 Apr; 172(4):423-32. PubMed ID: 25733068
[TBL] [Abstract][Full Text] [Related]
7. Independent and opposite associations of serum levels of omentin-1 and adiponectin with increases of glycaemia and incident type 2 diabetes in an older population: KORA F4/FF4 study.
Herder C; Kannenberg JM; Niersmann C; Huth C; Carstensen-Kirberg M; Wittenbecher C; Schulze M; Blüher M; Rathmann W; Peters A; Roden M; Meisinger C; Thorand B
Eur J Endocrinol; 2017 Oct; 177(4):277-286. PubMed ID: 28679518
[TBL] [Abstract][Full Text] [Related]
8. Maternal and neonatal omentin-1 levels in gestational diabetes.
Franz M; Polterauer M; Springer S; Kuessel L; Haslinger P; Worda C; Worda K
Arch Gynecol Obstet; 2018 Apr; 297(4):885-889. PubMed ID: 29335783
[TBL] [Abstract][Full Text] [Related]
9. Effects of the long-acting human glucagon-like peptide-1 analog liraglutide on plasma omentin-1 levels in patients with type 2 diabetes mellitus.
Yan P; Li L; Yang M; Liu D; Liu H; Boden G; Yang G
Diabetes Res Clin Pract; 2011 Jun; 92(3):368-74. PubMed ID: 21458097
[TBL] [Abstract][Full Text] [Related]
10. Serum omentin-1 levels in diabetic and nondiabetic patients with chronic kidney disease.
Tekce H; Tekce BK; Aktas G; Alcelik A; Sengul E
Exp Clin Endocrinol Diabetes; 2014 Sep; 122(8):451-6. PubMed ID: 24918534
[TBL] [Abstract][Full Text] [Related]
11. Changes of serum omentin-1 levels in normal subjects, type 2 diabetes and type 2 diabetes with overweight and obesity in Chinese adults.
Zhang Q; Zhu L; Zheng M; Fan C; Li Y; Zhang D; He Y; Yang H
Ann Endocrinol (Paris); 2014 Jul; 75(3):171-5. PubMed ID: 24997770
[TBL] [Abstract][Full Text] [Related]
12. Changes of serum omentin levels and relationship between omentin and adiponectin concentrations in type 2 diabetes mellitus.
Yan P; Liu D; Long M; Ren Y; Pang J; Li R
Exp Clin Endocrinol Diabetes; 2011 Apr; 119(4):257-63. PubMed ID: 21374544
[TBL] [Abstract][Full Text] [Related]
13. The normoglycemic first-degree relatives of patients with type 2 diabetes mellitus have low circulating omentin-1 and adiponectin levels.
Akbarzadeh S; Nabipour I; Assadi M; Movahed A; Jafari SM; Motamed N; Nazem H; Haraghy M; Pourbehi A; Bargahi A; Hajian N
Cytokine; 2012 May; 58(2):295-9. PubMed ID: 22398372
[TBL] [Abstract][Full Text] [Related]
14. Plasma omentin-1 levels are reduced in non-obese women with normal glucose tolerance and polycystic ovary syndrome.
Choi JH; Rhee EJ; Kim KH; Woo HY; Lee WY; Sung KC
Eur J Endocrinol; 2011 Nov; 165(5):789-96. PubMed ID: 21865408
[TBL] [Abstract][Full Text] [Related]
15. Association of serum omentin levels with cardiac autonomic neuropathy in patients with type 2 diabetes mellitus: a hospital-based study.
Jung CH; Jung SH; Kim BY; Kim CH; Kang SK; Mok JO
Cardiovasc Diabetol; 2015 Oct; 14():140. PubMed ID: 26466574
[TBL] [Abstract][Full Text] [Related]
16. Omentin, an adipokine with insulin-sensitizing properties, is negatively associated with insulin resistance in normal gestation.
Brandt B; Mazaki-Tovi S; Hemi R; Yinon Y; Schiff E; Mashiach R; Kanety H; Sivan E
J Perinat Med; 2015 May; 43(3):325-31. PubMed ID: 25324439
[TBL] [Abstract][Full Text] [Related]
17. Omentin-1 and NAMPT serum concentrations are higher and CK-18 levels are lower in children and adolescents with type 1 diabetes when compared to healthy age, sex and BMI matched controls.
Nurten E; Vogel M; Michael Kapellen T; Richter S; Garten A; Penke M; Schuster S; Körner A; Kiess W; Kratzsch J
J Pediatr Endocrinol Metab; 2018 Sep; 31(9):959-969. PubMed ID: 30179852
[TBL] [Abstract][Full Text] [Related]
18. The response of circulating omentin-1 concentration to 16-week exercise training in male children with obesity.
Zehsaz F; Farhangi N; Ghahramani M
Phys Sportsmed; 2016 Nov; 44(4):355-361. PubMed ID: 27737602
[TBL] [Abstract][Full Text] [Related]
19. Pharmacodynamic Effects of Low-Dose Pioglitazone in Patients with the Metabolic Syndrome without Diabetes Mellitus.
Vu A; Kosmiski LA; Beitelshees AL; Prigeon R; Sidhom MS; Bredbeck B; Predhomme J; Deininger KM; Aquilante CL
Pharmacotherapy; 2016 Mar; 36(3):252-62. PubMed ID: 26822630
[TBL] [Abstract][Full Text] [Related]
20. Effects of exenatide and metformin in combination on some adipocytokine levels: a comparison with metformin monotherapy.
Derosa G; Cicero AF; Franzetti IG; Querci F; Carbone A; Ciccarelli L; D'Angelo A; Fogari E; Maffioli P
Can J Physiol Pharmacol; 2013 Sep; 91(9):724-32. PubMed ID: 23984793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
